- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT00054054
S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Docetaxel (NSC-628503), Cisplatin (NSC-119875), And 5-Fluorouracil (NSC-19893) Induction Chemotherapy Followed By Accelerated Fractionation/Concomitant Boost Radiation And Concurrent Single Agent Cisplatin (NSC-119875), In Patients With Advanced Squamous Cell Head And Neck Cancer
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining more than one chemotherapy drug with radiation therapy may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy and radiation therapy in treating patients with stage III or stage IV head and neck cancer.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
OBJECTIVES:
- Determine the overall survival of patients with stage III or IV squamous cell head and neck cancer treated with docetaxel, cisplatin, and fluorouracil followed by accelerated fractionation/concomitant boost radiotherapy and cisplatin.
- Determine the unconfirmed complete response rate in these patients after treatment with induction chemotherapy.
- Determine the overall complete response rate (confirmed and unconfirmed) in patients treated with this regimen.
- Determine the toxic effects of this regimen in these patients.
OUTLINE:
- Induction Chemotherapy: Patients receive docetaxel IV over 1 hour and cisplatin IV over 30-60 minutes on day 1 and fluorouracil IV continuously on days 1-4. Treatment repeats every 21 days for 2 courses in the absence of unacceptable toxicity.
- Chemoradiotherapy: Beginning within 3-4 weeks after administration of the second course of induction chemotherapy, patients receive accelerated fractionation radiotherapy once daily, 5 days per week, for 6 weeks with concomitant boost radiotherapy once daily, 5 days a week, for the last 2.5 weeks of radiotherapy. Patients also receive concurrent cisplatin IV over 30-60 minutes on days 1 and 22.
Patients are followed every 2 months for 1 year, every 3 months for 2 years, every 4 months for 1 year, and then every 6 months for 1 year.
PROJECTED ACCRUAL: A total of 60 patients will be accrued for this study within 2 years.
Studietype
Fase
- Fase 2
Contacten en locaties
Studie Locaties
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- Hospital for Sick Children
-
-
-
-
Alabama
-
Birmingham, Alabama, Verenigde Staten, 35294-3300
- University of Alabama at Birmingham Comprehensive Cancer Center
-
Mobile, Alabama, Verenigde Staten, 36607
- MBCCOP - Gulf Coast
-
-
Arizona
-
Phoenix, Arizona, Verenigde Staten, 85006-2726
- CCOP - Western Regional, Arizona
-
Phoenix, Arizona, Verenigde Staten, 85012
- Veterans Affairs Medical Center - Phoenix (Carl T. Hayden)
-
Tucson, Arizona, Verenigde Staten, 85723
- Veterans Affairs Medical Center - Tucson
-
Tucson, Arizona, Verenigde Staten, 85724
- Arizona Cancer Center at University of Arizona Health Sciences Center
-
-
Arkansas
-
Little Rock, Arkansas, Verenigde Staten, 72205
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
-
Little Rock, Arkansas, Verenigde Staten, 72205
- Veterans Affairs Medical Center - Little Rock (McClellan)
-
-
California
-
Duarte, California, Verenigde Staten, 91010-3000
- City of Hope Comprehensive Cancer Center
-
Fresno, California, Verenigde Staten, 93720
- California Cancer Center
-
Los Angeles, California, Verenigde Staten, 90033
- USC/Norris Comprehensive Cancer Center and Hospital
-
Martinez, California, Verenigde Staten, 94553
- Veterans Affairs Outpatient Clinic - Martinez
-
Oakland, California, Verenigde Staten, 94609-3305
- CCOP - Bay Area Tumor Institute
-
Orange, California, Verenigde Staten, 92868
- Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center
-
Sacramento, California, Verenigde Staten, 95817
- University of California Davis Cancer Center
-
Santa Rosa, California, Verenigde Staten, 95403
- CCOP - Santa Rosa Memorial Hospital
-
Travis Air Force Base, California, Verenigde Staten, 94535
- David Grant Medical Center
-
-
Colorado
-
Aurora, Colorado, Verenigde Staten, 80010
- University of Colorado Cancer Center at University of Colorado Health Sciences Center
-
Denver, Colorado, Verenigde Staten, 80220
- Veterans Affairs Medical Center - Denver
-
-
District of Columbia
-
Washington, District of Columbia, Verenigde Staten, 20060
- MBCCOP - Howard University Cancer Center
-
-
Florida
-
Tampa, Florida, Verenigde Staten, 33612
- Veterans Affairs Medical Center - Tampa (Haley)
-
-
Georgia
-
Atlanta, Georgia, Verenigde Staten, 30342-1701
- CCOP - Atlanta Regional
-
-
Hawaii
-
Honolulu, Hawaii, Verenigde Staten, 96813
- MBCCOP - Hawaii
-
-
Illinois
-
Chicago, Illinois, Verenigde Staten, 60612
- Veterans Affairs Medical Center - Chicago (Westside Hospital)
-
Chicago, Illinois, Verenigde Staten, 60612
- MBCCOP - University of Illinois at Chicago
-
Decatur, Illinois, Verenigde Staten, 62526
- CCOP - Central Illinois
-
Hines, Illinois, Verenigde Staten, 60141
- Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital)
-
Maywood, Illinois, Verenigde Staten, 60153-5500
- Cardinal Bernardin Cancer Center at Loyola University Medical Center
-
-
Kansas
-
Kansas City, Kansas, Verenigde Staten, 66160-7353
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
-
Wichita, Kansas, Verenigde Staten, 67214-3882
- CCOP - Wichita
-
Wichita, Kansas, Verenigde Staten, 67218
- Veterans Affairs Medical Center - Wichita
-
-
Kentucky
-
Lexington, Kentucky, Verenigde Staten, 40502-2236
- Veterans Affairs Medical Center - Lexington
-
Lexington, Kentucky, Verenigde Staten, 40536-0084
- Markey Cancer Center at University of Kentucky Chandler Medical Center
-
-
Louisiana
-
New Orleans, Louisiana, Verenigde Staten, 70112
- Veterans Affairs Medical Center - New Orleans
-
New Orleans, Louisiana, Verenigde Staten, 70112
- MBCCOP - LSU Health Sciences Center
-
New Orleans, Louisiana, Verenigde Staten, 70112
- Tulane Cancer Center at Tulane University Hospital and Clinic
-
Shreveport, Louisiana, Verenigde Staten, 71130-3932
- Louisiana State University Health Sciences Center - Shreveport
-
Shreveport, Louisiana, Verenigde Staten, 71101-4295
- Veterans Affairs Medical Center - Shreveport
-
-
Massachusetts
-
Boston, Massachusetts, Verenigde Staten, 02118
- Cancer Research Center at Boston Medical Center
-
-
Michigan
-
Ann Arbor, Michigan, Verenigde Staten, 48105
- Veterans Affairs Medical Center - Ann Arbor
-
Ann Arbor, Michigan, Verenigde Staten, 48106
- CCOP - Michigan Cancer Research Consortium
-
Ann Arbor, Michigan, Verenigde Staten, 48109-0912
- University of Michigan Comprehensive Cancer Center
-
Detroit, Michigan, Verenigde Staten, 48202
- Josephine Ford Cancer Center at Henry Ford Hospital
-
Detroit, Michigan, Verenigde Staten, 48201-1379
- Barbara Ann Karmanos Cancer Institute
-
Detroit, Michigan, Verenigde Staten, 48201-1932
- Veterans Affairs Medical Center - Detroit
-
Grand Rapids, Michigan, Verenigde Staten, 49503
- CCOP - Grand Rapids
-
Royal Oak, Michigan, Verenigde Staten, 48073-6769
- CCOP - Beaumont
-
Southfield, Michigan, Verenigde Staten, 48075
- Providence Cancer Institute at Providence Hospital
-
-
Mississippi
-
Jackson, Mississippi, Verenigde Staten, 39216-4505
- University of Mississippi Medical Center
-
Jackson, Mississippi, Verenigde Staten, 39216
- Veterans Affairs Medical Center - Jackson
-
-
Missouri
-
Kansas City, Missouri, Verenigde Staten, 64131
- CCOP - Kansas City
-
Saint Louis, Missouri, Verenigde Staten, 63141
- CCOP - St. Louis-Cape Girardeau
-
Saint Louis, Missouri, Verenigde Staten, 63110
- St. Louis University Hospital Cancer Center
-
Springfield, Missouri, Verenigde Staten, 65807
- CCOP - Cancer Research for the Ozarks
-
-
Montana
-
Billings, Montana, Verenigde Staten, 59101
- CCOP - Montana Cancer Consortium
-
-
New Jersey
-
East Orange, New Jersey, Verenigde Staten, 07018-1095
- Veterans Affairs Medical Center - East Orange
-
-
New Mexico
-
Albuquerque, New Mexico, Verenigde Staten, 87108-5138
- Veterans Affairs Medical Center - Albuquerque
-
Albuquerque, New Mexico, Verenigde Staten, 87131
- MBCCOP - University of New Mexico HSC
-
-
New York
-
New York, New York, Verenigde Staten, 10016
- NYU School of Medicine's Kaplan Comprehensive Cancer Center
-
New York, New York, Verenigde Staten, 10032
- Herbert Irving Comprehensive Cancer Center at Columbia University
-
Rochester, New York, Verenigde Staten, 14642
- James P. Wilmot Cancer Center at University of Rochester Medical Center
-
-
North Carolina
-
Salisbury, North Carolina, Verenigde Staten, 28144
- Veterans Affairs Medical Center - Salisbury
-
Winston-Salem, North Carolina, Verenigde Staten, 27104-4241
- CCOP - Southeast Cancer Control Consortium
-
-
Ohio
-
Cincinnati, Ohio, Verenigde Staten, 45220-2288
- Veterans Affairs Medical Center - Cincinnati
-
Cincinnati, Ohio, Verenigde Staten, 45267-0501
- Charles M. Barrett Cancer Center at University Hospital
-
Cleveland, Ohio, Verenigde Staten, 44195-9001
- Cleveland Clinic Taussig Cancer Center
-
Columbus, Ohio, Verenigde Staten, 43206
- CCOP - Columbus
-
Dayton, Ohio, Verenigde Staten, 45429
- CCOP - Dayton
-
Dayton, Ohio, Verenigde Staten, 45428-1002
- Veterans Affairs Medical Center - Dayton
-
-
Oregon
-
Portland, Oregon, Verenigde Staten, 97207
- Veterans Affairs Medical Center - Portland
-
Portland, Oregon, Verenigde Staten, 97225
- CCOP - Columbia River Oncology Program
-
Portland, Oregon, Verenigde Staten, 97201-3098
- Cancer Institute at Oregon Health and Science University
-
-
South Carolina
-
Charleston, South Carolina, Verenigde Staten, 29425
- Hollings Cancer Center at Medical University of South Carolina
-
Charleston, South Carolina, Verenigde Staten, 29401-5799
- Veterans Affairs Medical Center - Charleston
-
Greenville, South Carolina, Verenigde Staten, 29615
- CCOP - Greenville
-
Spartanburg, South Carolina, Verenigde Staten, 29303
- CCOP - Upstate Carolina
-
-
Tennessee
-
Memphis, Tennessee, Verenigde Staten, 38104
- University of Tennessee Cancer Institute
-
-
Texas
-
Amarillo, Texas, Verenigde Staten, 79106
- Harrington Cancer Center
-
Amarillo, Texas, Verenigde Staten, 79106
- Veterans Affairs Medical Center - Amarillo
-
Fort Sam Houston, Texas, Verenigde Staten, 78234-6200
- Brooke Army Medical Center
-
Galveston, Texas, Verenigde Staten, 77555-0565
- University of Texas Medical Branch
-
Houston, Texas, Verenigde Staten, 77030
- Veterans Affairs Medical Center - Houston
-
Houston, Texas, Verenigde Staten, 77030-4095
- University of Texas - MD Anderson Cancer Center
-
San Antonio, Texas, Verenigde Staten, 78229-3900
- University of Texas Health Science Center at San Antonio
-
San Antonio, Texas, Verenigde Staten, 78229
- Veterans Affairs Medical Center - San Antonio (Murphy)
-
Temple, Texas, Verenigde Staten, 76504
- Veterans Affairs Medical Center - Temple
-
Temple, Texas, Verenigde Staten, 76508
- CCOP - Scott and White Hospital
-
-
Utah
-
Salt Lake City, Utah, Verenigde Staten, 84148
- Veterans Affairs Medical Center - Salt Lake City
-
Salt Lake City, Utah, Verenigde Staten, 84112-5550
- Huntsman Cancer Institute
-
-
Washington
-
Seattle, Washington, Verenigde Staten, 98101
- CCOP - Virginia Mason Research Center
-
Seattle, Washington, Verenigde Staten, 98108
- Veterans Affairs Medical Center - Seattle
-
Seattle, Washington, Verenigde Staten, 98109
- Puget Sound Oncology Consortium
-
Tacoma, Washington, Verenigde Staten, 98431-5000
- Madigan Army Medical Center
-
Tacoma, Washington, Verenigde Staten, 98405-0986
- CCOP - Northwest
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
DISEASE CHARACTERISTICS:
Histologically confirmed squamous cell carcinoma of the head and neck (excluding lip, nasopharynx, paranasal sinus, and salivary gland) by biopsy or fine needle aspirate of the primary lesion or neck mass
- Stage III or IV disease
No evidence of distant metastases
- Negative chest x-ray
Primary site in the head and neck region must be identified
- No unknown primary site
- Considered to be appropriate for definitive radiotherapy with curative intent
PATIENT CHARACTERISTICS:
Age
- 18 and over
Performance status
- Zubrod 0-1
Life expectancy
- Not specified
Hematopoietic
- Granulocyte count greater than 1,500/mm^3
- Platelet count greater than 100,000/mm^3
Hepatic
- Bilirubin no greater than upper limit of normal (ULN)
- Alkaline phosphatase less than 2 times ULN
- ALT or AST less than 1.5 times ULN
Renal
- Creatinine less than 1.5 mg/dL
Cardiovascular
- No myocardial infarction within the past 3 months
- No unstable or uncontrolled angina
Other
- Not pregnant or nursing
- Fertile patients must use effective contraception
- No other prior malignancy within the past 5 years except adequately treated basal cell or squamous cell skin cancer, carcinoma in situ of the cervix, or adequately treated stage I or II cancer currently in complete remission
- No evidence of pre-existing peripheral neuropathy
- No active systemic infection
- No history of hypersensitivity reaction to products containing polysorbate 80
PRIOR CONCURRENT THERAPY:
Biologic therapy
- Not specified
Chemotherapy
- No prior chemotherapy
Endocrine therapy
- Not specified
Radiotherapy
- See Disease Characteristics
- No prior radiotherapy
Surgery
- No prior surgery for head or neck cancer
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
Medewerkers en onderzoekers
Sponsor
Medewerkers
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
- stadium III plaveiselcelcarcinoom van de orofarynx
- stadium IV plaveiselcelcarcinoom van de orofarynx
- stadium III plaveiselcelcarcinoom van de hypofarynx
- stadium IV plaveiselcelcarcinoom van de hypofarynx
- stadium III plaveiselcelcarcinoom van het strottenhoofd
- stadium IV plaveiselcelcarcinoom van het strottenhoofd
Aanvullende relevante MeSH-voorwaarden
- Neoplasmata
- Neoplasmata per site
- Hoofd- en nekneoplasmata
- Fysiologische effecten van medicijnen
- Moleculaire mechanismen van farmacologische werking
- Antimetabolieten, antineoplastische
- Antimetabolieten
- Antineoplastische middelen
- Immunosuppressieve middelen
- Immunologische factoren
- Tubuline-modulatoren
- Antimitotische middelen
- Mitose modulatoren
- Docetaxel
- Fluoruracil
Andere studie-ID-nummers
- CDR0000269781
- U10CA032102 (Subsidie/contract van de Amerikaanse NIH)
- S0216 (Andere identificatie: SWOG)
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op docetaxel
-
Nereus Pharmaceuticals, Inc.VoltooidKankerVerenigde Staten, Australië, Indië, Chili, Brazilië, Argentinië
-
Tianjin Medical University Cancer Institute and...Werving
-
Optimal Health ResearchVoltooidBorstkanker | Longkanker | ProstaatkankerVerenigde Staten
-
National Cancer Center, KoreaSeoul National University Bundang Hospital; Gachon University Gil Medical Center en andere medewerkersOnbekend
-
Arog Pharmaceuticals, Inc.IngetrokkenCarcinoom, niet-kleincellige long
-
Zhuhai Beihai Biotech Co., LtdVoltooidVaste tumoren | Bio-equivalentie | DocetaxelIndië
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai Pulmonary Hospital, Shanghai, ChinaVoltooidNiet-kleincellige longkanker (NSCLC)China
-
SanofiVoltooidLongneoplasmataFrankrijk, Nederland, Spanje, Kalkoen, België, Finland, Italië, Verenigd Koninkrijk
-
Australian and New Zealand Urogenital and Prostate...Peter MacCallum Cancer Centre, AustraliaWervingCastratieresistente prostaatkankerAustralië
-
SanofiVoltooid